Increasing the predictability of cloprostenol-induced farrowing in sows
Roy Neville Kirkwood, F. X. AHERNE
Abstract
Roy Neville Kirkwood, F. X. AHERNE
Abstract
Methods: Two experiments were conducted. In experiment 1, sows received one of two treatments: either a single IM injection of 175 μg cloprostenol at day 113 of gestation (n=49) or an IM injection of 175 μg cloprostenol at day 113 of gestation followed by second IM injection of 175 μg cloprostenol 6 hours later (n=54). In experiment 2, sows received either a single (n=59) or a double (n=48) cloprostenol injection, as above, or a third treatment in which an IM injection of 30 IU oxytocin (n=56) replaced the second cloprostenol injection.
OpenAlex reports 28 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Methods: Two experiments were conducted. In experiment 1, sows received one of two treatments: either a single IM injection of 175 μg cloprostenol at day 113 of gestation (n=49) or an IM injection of 175 μg cloprostenol at day 113 of gestation followed by second IM injection of 175 μg cloprostenol 6 hours later (n=54). In experiment 2, sows received either a single (n=59) or a double (n=48) cloprostenol injection, as above, or a third treatment in which an IM injection of 30 IU oxytocin (n=56) replaced the second cloprostenol injection.
Key concepts: Cloprostenol, Gestation, Animal science, Oxytocin, Medicine, Prostaglandin analogue, Pregnancy, Internal medicine